6640--Cobas 6800 HPV Reagents
Veterans Affairs · 242-NETWORK CONTRACT OFFICE 02 (36C242)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24226Q0922 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
This is a Notice of Intent published in accordance with Federal Acquisition Regulation (FAR) 5.101(a) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source, firm-fixed price contract under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 6.103-1 - Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. It is not a request for competitive quotes. The Department of Veterans Affairs, Network Contracting Office 02 intends to award a sole source firm fixed pri… (show all)
ce contract to Roche Diagnostics for Cobas 6800 HPV reagents and supplies for the Buffalo VA Medical Center. Cobas 6800 HPV reagents and supplies are required from Roche Diagnostics in accordance with 41 U.S.C. 3304(a)(1), as implemented by FAR 6.103-1 - Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, because the facility requires reagents and associated consumables that are compatible with the existing Cobas 6800 instrument owned and operated by the facility. These reagents and supplies are proprietary products manufactured exclusively by Roche Diagnostics. The North American Industry Classification System (NAICS) code for this requirement is 334516 - Analytical Laboratory Instrument Manufacturing. The Product/Service Code is 6640 - Laboratory Equipment and Supplies. While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement. All responsible sources may submit a capability statement which shall be considered by the agency. The Government understands that Roche Diagnostics is the only vendor that can provide the required Cobas 6800 HPV reagents and supplies. However, vendors that believe they can provide the capabilities required to fully meet the Government's requirement may submit information in writing to Jonathan Kilgore, Contracting Officer at Jonathan.kilgore@va.gov no later than September 2, 2026, at 8:00 AM EST. Such documentation will be reviewed solely for the purpose of determining whether or not to conduct the procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Who won similar work
17 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 334516.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $6.3M | Jun 1, 2026 |
| BECKMAN COULTER, INC | 2 | $3.0M | Oct 13, 2026 |
| ROCHE DIAGNOSTICS CORPORATION | 2 | $2.0M | Jul 1, 2026 |
| VETERANS HEALTHCARE SUPPLY SOLUTIONS, INC | 2 | $183K | Aug 28, 2025 |
| DIASORIN INC | 1 | $1.2M | May 4, 2026 |
| CEPHEID SUNNYVALE 94089 | 1 | $1.1M | Apr 2, 2026 |
| NOVA BIOMEDICAL CORP | 1 | $1.1M | Sep 28, 2026 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 1 | $1.1M | Oct 9, 2025 |
| HELENA LABORATORIES CORPORATION | 1 | $670K | Apr 1, 2025 |
| GEO-MED, LLC | 1 | $348K | May 5, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 13, 2026BECKMAN COULTER, INC$1.4M6632--Chemistry/Immunoassay CPRR
- Oct 13, 2026BECKMAN COULTER, INC$1.6M6632--Chemistry/Immunoassay CPRR
- Sep 28, 2026NOVA BIOMEDICAL CORP$1.1M6550--Glucose Point of Care (POC) Testing
- Jul 1, 2026ROCHE DIAGNOSTICS CORPORATION$1.1MViral Load Molecular Testing
- Jun 1, 2026SYSMEX AMERICA, INC$5.9MVISN2 DOWNSTATE HEMATOLOGY CPRR
- May 5, 2026GEO-MED, LLC$348K6515--Lightstrike UV Disinfectant Robot
- May 4, 2026DIASORIN INC$1.2M6632--Award Notice - Infectious Disease and Bacterial Markers CPRR
- Apr 23, 2026GOVERNMENT SCIENTIFIC SOURCE INC$74K6640--Tissue Processor for Albany VA Medical Center
- Apr 13, 2026STRIPES GLOBAL, INC.$136K6640--528-23-2-4307-0381 CPR Flowcytometry testing for VISN2
- Apr 2, 2026CEPHEID SUNNYVALE 94089$1.1M6640--Lab - Cepheid PCR Molecular Testing
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.